Empowering mental health professionals with peer-reviewed psychiatric research and insights
Page 5
More JCP Articles
Brief Report
Cannabis and Attention Deficit Disorder in Community Mental Health
October 14, 2024
The finding that 73% of patients with both ADHD and cannabis use were prescribed stimulant medications necessitates enhanced training and education for clinicians on appropriate prescription of stimulants.
Insights
Optimizing Recovery: Comprehensive Care Pathways for Depression
October 7, 2024
In this video, Dr. Jay Fournier discusses the challenges of outpatient depression care, including access issues, placebo response, and maintaining sustained remission. He outlines a stepped approach to treatment…
Insights
Surgical Interventions in Treatment Resistant Depression
October 7, 2024
Patricio Riva Posse, MD, discusses advanced surgical interventions for treatment-resistant depression, including vagus nerve and deep brain stimulation. This presentation explores relapse rates, alternative therapies, and the potential for…
Insights
Algorithms for TRD Treatment Success
September 27, 2024
Dr. Nolan Williams delves into the innovative Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT) for treating resistant depression. Explore groundbreaking research, clinical trials, and the transformative potential of personalized brain…
Information from Industry
Auvelity: A Rapid-Acting Antidepressant With Multimodal Activity
September 27, 2024
AUVELITY is an FDA-approved treatment for adults with MDD. Auvelity, is a rapid-acting antidepressant with a multimodal mechanism, targeting both glutamatergic and monoaminergic pathways. Learn more about how AUVELITY…
Educational Activity
Emerging Approaches in Schizophrenia
September 26, 2024
This collection from Psychiatrist.com News highlights the latest developments in schizophrenia treatment, emphasizing new therapies that go beyond traditional dopaminergic approaches. Clinicians will gain insights into managing symptoms, cognitive…
